These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23053887)

  • 1. Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.
    Mohana Devi S; Balachandar V; Arun M; Suresh Kumar S; Balamurali Krishnan B; Sasikala K
    Dig Dis Sci; 2013 Mar; 58(3):759-67. PubMed ID: 23053887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk.
    Yuan T; Wei J; Luo J; Liu M; Deng S; Chen P
    Dig Dis Sci; 2012 Sep; 57(9):2451-7. PubMed ID: 22565339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
    Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
    Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
    Naguib M; Helwa MM; Soliman MM; Abdel-Samiee M; Eljaky AM; Hammam O; Zaghla H; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1031-1037. PubMed ID: 32334466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of base-excision repair genes and the hepatocarcinogenesis.
    Mattar MM; Zekri AN; Hussein N; Morsy H; Esmat G; Amin MA
    Gene; 2018 Oct; 675():62-68. PubMed ID: 29935355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
    Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population.
    Kiran M; Saxena R; Chawla YK; Kaur J
    Mol Cell Biochem; 2009 Jul; 327(1-2):7-13. PubMed ID: 19194663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.
    Long XD; Ma Y; Huang HD; Yao JG; Qu DY; Lu YL
    Mol Carcinog; 2008 Apr; 47(4):295-300. PubMed ID: 17849423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the C.1161G>A and C.1779C>G genetic variants of XRCC1 gene and hepatocellular carcinoma risk in Chinese population.
    Deng X; Liang J; Jiang M; Zhou X; Liu H
    Int J Biol Sci; 2013; 9(3):289-94. PubMed ID: 23493666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    Xiong Y; Zhang Q; Ye J; Pan S; Ge L
    PLoS One; 2018; 13(11):e0206853. PubMed ID: 30408066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
    Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
    Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
    Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population.
    Pan HZ; Liang J; Yu Z; Lun LM; Li H; Wang Q
    Asian Pac J Cancer Prev; 2011; 12(11):2947-50. PubMed ID: 22393969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
    Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
    Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
    Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.